Sigma Planning Corp’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,939
| Closed | -$230K | – | 1247 |
|
|
2024
Q2 | $230K | Sell |
1,939
-1,374
| -41% | -$163K | 0.01% | 1026 |
|
|
2024
Q1 | $353K | Buy |
3,313
+536
| +19% | +$57.1K | 0.01% | 885 |
|
|
2023
Q4 | $276K | Sell |
2,777
-7,228
| -72% | -$719K | 0.02% | 653 |
|
|
2023
Q3 | $1.03M | Sell |
10,005
-1,528
| -13% | -$158K | 0.04% | 454 |
|
|
2023
Q2 | $1.4M | Buy |
11,533
+137
| +1% | +$16.6K | 0.05% | 363 |
|
|
2023
Q1 | $1.75M | Sell |
11,396
-671
| -6% | -$103K | 0.06% | 333 |
|
|
2022
Q4 | $2.17M | Buy |
12,067
+639
| +6% | +$115K | 0.08% | 267 |
|
|
2022
Q3 | $1.35M | Sell |
11,428
-89
| -0.8% | -$10.5K | 0.05% | 353 |
|
|
2022
Q2 | $1.65M | Buy |
11,517
+46
| +0.4% | +$6.57K | 0.06% | 313 |
|
|
2022
Q1 | $1.98M | Sell |
11,471
-549
| -5% | -$94.6K | 0.06% | 317 |
|
|
2021
Q4 | $3.05M | Sell |
12,020
-15,178
| -56% | -$3.86M | 0.09% | 237 |
|
|
2021
Q3 | $10.5M | Buy |
27,198
+13,973
| +106% | +$5.38M | 0.31% | 57 |
|
|
2021
Q2 | $3.11M | Buy |
13,225
+397
| +3% | +$93.3K | 0.09% | 236 |
|
|
2021
Q1 | $1.68M | Sell |
12,828
-408
| -3% | -$53.4K | 0.05% | 358 |
|
|
2020
Q4 | $1.38M | Sell |
13,236
-3,862
| -23% | -$404K | 0.05% | 360 |
|
|
2020
Q3 | $1.21M | Sell |
17,098
-1,015
| -6% | -$71.8K | 0.05% | 349 |
|
|
2020
Q2 | $1.16M | Buy |
18,113
+7,958
| +78% | +$511K | 0.05% | 347 |
|
|
2020
Q1 | $304K | Buy |
+10,155
| New | +$304K | 0.02% | 641 |
|